201 related articles for article (PubMed ID: 26740400)
1. Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and α-synuclein aggregation in 6-OHDA induced parkinson's disease cell model.
Zhang Z; Hou L; Li X; Ju C; Zhang J; Li X; Wang X; Liu C; Lv Y; Wang Y
Brain Res; 2016 Feb; 1633():87-95. PubMed ID: 26740400
[TBL] [Abstract][Full Text] [Related]
2. Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: Reciprocal up-regulation of E6-AP and down-regulation of α-synuclein.
Ham A; Kim DW; Kim KH; Lee SJ; Oh KB; Shin J; Mar W
Brain Res; 2013 Aug; 1524():54-61. PubMed ID: 23751361
[TBL] [Abstract][Full Text] [Related]
3. Influence of 6-Hydroxydopamine Toxicity on α-Synuclein Phosphorylation, Resting Vesicle Expression, and Vesicular Dopamine Release.
Ganapathy K; Datta I; Sowmithra S; Joshi P; Bhonde R
J Cell Biochem; 2016 Dec; 117(12):2719-2736. PubMed ID: 27064513
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
Turan D; Abdik H; Sahin F; Avşar Abdik E
Eur J Pharmacol; 2020 Sep; 883():173342. PubMed ID: 32634439
[TBL] [Abstract][Full Text] [Related]
5. Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons.
Hwang CK; Chun HS
Biosci Biotechnol Biochem; 2012; 76(3):536-43. PubMed ID: 22451397
[TBL] [Abstract][Full Text] [Related]
6. Involvement of activation of the Nrf2/ARE pathway in protection against 6-OHDA-induced SH-SY5Y cell death by α-iso-cubebenol.
Park SY; Kim DY; Kang JK; Park G; Choi YW
Neurotoxicology; 2014 Sep; 44():160-8. PubMed ID: 24997245
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells.
Karmakar S; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2094-102. PubMed ID: 17616815
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Ikeda Y; Tsuji S; Satoh A; Ishikura M; Shirasawa T; Shimizu T
J Neurochem; 2008 Dec; 107(6):1730-40. PubMed ID: 19014378
[TBL] [Abstract][Full Text] [Related]
9. Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson's Model in Rats.
Mishra A; Krishnamurthy S
Neurotox Res; 2019 Apr; 35(3):542-562. PubMed ID: 30610666
[TBL] [Abstract][Full Text] [Related]
10. Morphine protects SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cell damage: involvement of anti-oxidant, calcium blocking, and anti-apoptotic properties.
Elyasi L; Eftekhar-Vaghefi SH; Esmaeili-Mahani S
Rejuvenation Res; 2014 Jun; 17(3):255-63. PubMed ID: 24341565
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells.
Sharma G; Singh RP; Agarwal R
Int J Oncol; 2003 Nov; 23(5):1413-8. PubMed ID: 14532984
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
Lin YC; Uang HW; Lin RJ; Chen IJ; Lo YC
J Pharmacol Exp Ther; 2007 Dec; 323(3):877-87. PubMed ID: 17855475
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease.
Xu Q; Kanthasamy AG; Reddy MB
Toxicology; 2008 Mar; 245(1-2):101-8. PubMed ID: 18255213
[TBL] [Abstract][Full Text] [Related]
16. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
Sharma N; Nehru B
Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
[TBL] [Abstract][Full Text] [Related]
17. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
[TBL] [Abstract][Full Text] [Related]
18. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways.
Gao QG; Chen WF; Xie JX; Wong MS
J Neurochem; 2009 Jun; 109(5):1338-47. PubMed ID: 19476546
[TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Neuropeptide Apelin-13 on 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Dopaminergic Cells: Involvement of Its Antioxidant and Antiapoptotic Properties.
Pouresmaeili-Babaki E; Esmaeili-Mahani S; Abbasnejad M; Ravan H
Rejuvenation Res; 2018 Apr; 21(2):162-167. PubMed ID: 28782414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
